Prevalence of diabetic peripheral neuropathy and its relation to glycaemic control and potential risk factors: the EURODIAB IDDM Complications Study
Open accessThe DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.
Abstract
The EURODIAB IDDM Complications Study involved the examination of 3250 randomly selected insulin-dependent diabetic patients, from 31 centres in 16 European countries. Part of the examination included an assessment of neurological function including neuropathic symptoms and physical signs, vibration perception threshold, tests of autonomic function and the prevalence of impotence. The prevalence of diabetic neuropathy across Europe was 28% with no significant geographical differences. Significant correlations were observed between the presence of diabetic peripheral neuropathy with age (p < 0.05), duration of diabetes (p < 0.001), quality of metabolic control (p < 0.001), height (p < 0.01), the presence of background or proliferative diabetic retinopathy (p < 0.01), cigarette smoking (p < 0.001), high-density lipoprotein cholesterol (p < 0.001) and the presence of cardiovascular disease (p < 0.05), thus confirming previous associations. New associations have been identified from this study - namely with elevated diastolic blood pressure (p < 0.05), the presence of severe ketoacidosis (p < 0.001), an increase in the levels of fasting triglyceride (p < 0.001), and the presence of microalbuminuria (p < 0.01). All the data were adjusted for age, duration of diabetes and HbA1c. Although alcohol intake correlated with absence of leg reflexes and autonomic dysfunction, there was no overall association of alcohol consumption and neuropathy. The reported problems of impotence were extremely variable between centres, suggesting many cultural and attitudinal differences in the collection of such information in different European countries. In conclusion, this study has identified previously known and new potential risk factors for the development of diabetic peripheral neuropathy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Furthermore, even in more contemporary cohorts with recent-onset T2D prevalence rates of up to 25% have been observed,545,546 including in youth417,612–615 or at different degrees of glucose intolerance.616”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [545]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Young, M. J., Boulton, A. J. M., Macleod, A. F., Williams, D. R. R., & Sonksen, P. H. (1993) · Diabetologia · doi:10.1007/bf00400697 · Cited by 1,502
Dyck, P. J., Kratz, K. M., Karnes, J. L., Litchy, W. J., Klein, R., Pach, J. M., Wilson, D. M., O'Brien, P. C., & Melton, L. J. (1993) · Neurology · doi:10.1212/wnl.43.4.817 · Cited by 1,482
The Value of Cardiovascular Autonomic Function Tests: 10 Years Experience in Diabetes
Ewing, D. J., Martyn, C. N., Young, R. J., & Clarke, B. F. (1985) · Diabetes Care · doi:10.2337/diacare.8.5.491 · Cited by 1,434 · cited 1×
“1) the presence of one or more symptoms; 2) absence of two or more ankle or knee reflexes; 3) vibration perception threshold which was abnormal relating to age-related measures [12] and 4) abnormal autonomic function assessed using Ewing’s definitons [13] of postural hypotension with a fall in systolic blood pressure…”
MethodPirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.3.168 · Cited by 1,290
Maser, R. E., Steenkiste, A. R., Dorman, J. S., Nielsen, V. K., Bass, E. B., Manjoo, Q., Drash, A. L., Becker, D. J., Kuller, L. H., Greene, D. A., et al. (1989) · Diabetes · doi:10.2337/diab.38.11.1456 · Cited by 408
Pirart, J. (1978) · Diabetes Care · doi:10.2337/diacare.1.4.252 · Cited by 358
Microvascular and acute complications in IDDM patients: the EURODIAB IDDM Complications Study
Stephenson, J., Fuller, J. H., & EUROBIAB IDDM Complications Study Group (1994) · Diabetologia · doi:10.1007/bf00398055 · Cited by 345
Self-citationReport and Recommendations of the San Antonio Conference on Diabetic Neuropathy
(1988) · Diabetes · doi:10.2337/diab.37.7.1000 · Cited by 308
Malik, R. A., Newrick, P. G., Sharma, A. K., Jennings, A., Ah-See, A. K., Mayhew, T. M., Jakubowski, J., Boulton, A. J. M., & Ward, J. D. (1989) · Diabetologia · doi:10.1007/bf00505180 · Cited by 294
Self-citationSENSORY NEUROPATHY IN NON-INSULIN-DEPENDENT DIABETES MELLITUS
FRANKLIN, G. M., KAHN, L. B., BAXTER, J., MARSHALL, J. A., & HAMMAN, R. F. (1990) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a115547 · Cited by 281
Cited by
Diabetic neuropathy: A position statement by the American Diabetes Association
Pop-Busui, R., Boulton, A. J. M., Feldman, E. L., Bril, V., Freeman, R., Malik, R. A., Sosenko, J. M., & Ziegler, D. (2017) · Diabetes Care · doi:10.2337/dc16-2042 · Cited by 2,602
“Estimates of the incidence and prevalence of DSPN vary greatly (25,38–40), but evidence from several large observational cohorts (41,42) and the DCCT/ EDIC (27,43) suggests that DSPN occurs in at least 20% of people with type 1 diabetes after 20 years of disease duration.”
BackgroundGenetics of diabetes mellitus and diabetes complications
Cole, J. B., & Florez, J. C. (2020) · Nature Reviews Nephrology · doi:10.1038/s41581-020-0278-5 · Cited by 1,797
Vascular risk factors and diabetic neuropathy
Tesfaye, S., Chaturvedi, N., Eaton, S. E. M., Ward, J. D., Manes, C., Ionescu-Tirgoviste, C., Witte, D. R., & Fuller, J. H. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa032782 · Cited by 1,323
Self-citationDiabetes-Related Microvascular and Macrovascular Diseases in the Physical Therapy Setting
Cade, W. T. (2008) · Physical Therapy · doi:10.2522/ptj.20080008 · Cited by 1,084
Boulton, A. J. M., Malik, R. A., Arezzo, J. C., & Sosenko, J. M. (2004) · Diabetes Care · doi:10.2337/diacare.27.6.1458 · Cited by 913
Abbott, C. A., Malik, R. A., van Ross, E. R. E., Kulkarni, J., & Boulton, A. J. M. (2011) · Diabetes Care · doi:10.2337/dc11-1108 · Cited by 868
Epidemiology of Peripheral Neuropathy and Lower Extremity Disease in Diabetes
Hicks, C. W., & Selvin, E. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1212-8 · Cited by 798
Diabetic neuropathy: Mechanisms to management
Edwards, J. L., Vincent, A. M., Cheng, H. T., & Feldman, E. L. (2008) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2008.05.005 · Cited by 790
Vascular factors and metabolic interactions in the pathogenesis of diabetic neuropathy
Cameron, N. E., Eaton, S. E. M., Cotter, M. A., & Tesfaye, S. (2001) · Diabetologia · doi:10.1007/s001250100001 · Cited by 701
Self-citationAdvances in the epidemiology, pathogenesis and management of diabetic peripheral neuropathy
Tesfaye, S., & Selvarajah, D. (2012) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2239 · Cited by 615
“4%, equivalent to Diabetes Control and Complications Trial HbA1c of 7%) still developed microvascular disease, suggesting that factors other than glycaemic control and disease duration are involved [9].”
BackgroundSelf-citationManagement of Diabetic Foot Ulcers
Alexiadou, K., & Doupis, J. (2012) · Diabetes Therapy · doi:10.1007/s13300-012-0004-9 · Cited by 565
“Diabetic neuropathy is the common factor in almost 90% of diabetic foot ulcers [9, 10].”
BackgroundGore, M., Brandenburg, N. A., Dukes, E., Hoffman, D. L., Tai, K.-S., & Stacey, B. (2005) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2005.04.009 · Cited by 525
Blonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy
Sloan, G., Selvarajah, D., & Tesfaye, S. (2021) · Nature Reviews Endocrinology · doi:10.1038/s41574-021-00496-z · Cited by 534
Self-citationThe current burden of diabetic foot disease
Edmonds, M., Manu, C., & Vas, P. (2021) · Journal of Clinical Orthopaedics and Trauma · doi:10.1016/j.jcot.2021.01.017 · Cited by 437
Validation of the Toronto Clinical Scoring System for diabetic polyneuropathy
Bril, V., & Perkins, B. A. (2002) · Diabetes Care · doi:10.2337/diacare.25.11.2048 · Cited by 472
“HbA1c as an index of long-term diabetes control has been shown to be related to the incidence and the prevalence of diabetic DSP in both cross-sectional and prospective epidemiological studies that primarily include patients with type 1 diabetes, such as the Pittsburgh Epidemiology of Diabetic Complications Study (19,…”
BackgroundDiabetes and risk of physical disability in adults: a systematic review and meta-analysis
Wong, E., Backholer, K., Gearon, E., Harding, J., Freak-Poli, R., Stevenson, C., & Peeters, A. (2013) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(13)70046-9 · Cited by 470
Daousi, C., MacFarlane, I. A., Woodward, A., Nurmikko, T. J., Bundred, P. E., & Benbow, S. J. (2004) · Diabetic Medicine · doi:10.1111/j.1464-5491.2004.01271.x · Cited by 454
Van Acker, K., Bouhassira, D., De Bacquer, D., Weiss, S., Matthys, K., Raemen, H., Mathieu, C., & Colin, I. M. (2009) · Diabetes & Metabolism · doi:10.1016/j.diabet.2008.11.004 · Cited by 408
Painful Diabetic Neuropathy: Epidemiology, Natural History, Early Diagnosis, and Treatment Options
Veves, A., Backonja, M., & Malik, R. A. (2008) · Pain Medicine · doi:10.1111/j.1526-4637.2007.00347.x · Cited by 375
Caselli, A., Pham, H., Giurini, J. M., Armstrong, D. G., & Veves, A. (2002) · Diabetes Care · doi:10.2337/diacare.25.6.1066 · Cited by 326
“An NDS score of 0 indicated absence of neuropathy, 1–5 mild neuropathy, 6–16 moderate neuropathy, and 17–28 severe neuropathy (11).”
BackgroundDiabetic foot ulcers: Classification, risk factors and management
Wang, X., Yuan, C.-X., Xu, B., & Yu, Z. (2022) · World Journal of Diabetes · doi:10.4239/wjd.v13.i12.1049 · Cited by 305
Electrical spinal-cord stimulation for painful diabetic peripheral neuropathy
Tesfaye, S., Watt, J., Benbow, S. J., Pang, K. A., Miles, J., & MacFarlane, I. A. (1996) · The Lancet · doi:10.1016/s0140-6736(96)02467-1 · Cited by 309
Self-citationGlucose Control and Diabetic Neuropathy: Lessons from Recent Large Clinical Trials
Ang, L., Jaiswal, M., Martin, C., & Pop-Busui, R. (2014) · Current Diabetes Reports · doi:10.1007/s11892-014-0528-7 · Cited by 303
Updates in diabetic peripheral neuropathy
Juster-Switlyk, K., & Smith, A. G. (2016) · F1000Research · doi:10.12688/f1000research.7898.1 · Cited by 288
“%) are at risk 33 .”
Malik, R. A., Williamson, S., Abbott, C., Carrington, A. L., Iqbal, J., Schady, W., & Boulton, A. J. (1998) · The Lancet · doi:10.1016/s0140-6736(98)02478-7 · Cited by 284
SEXUAL FUNCTION IN MEN WITH DIABETES TYPE 2: ASSOCIATION WITH GLYCEMIC CONTROL
ROMEO, J. H., SEFTEL, A. D., MADHUN, Z. T., & ARON, D. C. (2000) · Journal of Urology · doi:10.1016/s0022-5347(05)67805-6 · Cited by 274
Tamayo, T., Rosenbauer, J., Wild, S. H., Spijkerman, A. M. W., Baan, C., Forouhi, N. G., Herder, C., & Rathmann, W. (2014) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2013.11.007 · Cited by 247
“[92] Tesfaye S, Stevens LK, Stephenson JM, Fuller JH, Plater M, Ionescu-Tirgoviste C, et al.”
BackgroundTreatment of painful diabetic neuropathy
Javed, S., Petropoulos, I. N., Alam, U., & Malik, R. A. (2015) · Therapeutic Advances in Chronic Disease · doi:10.1177/2040622314552071 · Cited by 239
Diabetic neuropathy: cutting-edge research and future directions
Yang, Y., Zhao, B., Wang, Y., Lan, H., Liu, X., Hu, Y., & Cao, P. (2025) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-025-02175-1 · Cited by 234
“31,32 With more sensitive tests, the prevalence exceeds 50%.”
Molecular mechanisms beyond glucose transport in diabetes-related male infertility
Alves, M. G., Martins, A. D., Rato, L., Moreira, P. I., Socorro, S., & Oliveira, P. F. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2013.01.011 · Cited by 241
“In a population-based cohort study, there was an increase of ED in older men with DM [71] and it has been reported that the glycemic control is”
BackgroundThe risk factors for diabetic peripheral neuropathy: A meta-analysis
Liu, X., Xu, Y., An, M., & Zeng, Q. (2019) · PLOS ONE · doi:10.1371/journal.pone.0212574 · Cited by 242
Burden of Illness in Painful Diabetic Peripheral Neuropathy: The Patients’ Perspectives
Gore, M., Brandenburg, N. A., Hoffman, D. L., Tai, K.-S., & Stacey, B. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2006.04.013 · Cited by 239
Epidemiology of polyneuropathy in diabetes and prediabetes
(2014) · Handbook of Clinical Neurology · doi:10.1016/b978-0-444-53480-4.00001-1 · Cited by 235
“A number of other studies have also documented age as an independent risk factor for DSPN (Walters et al., 1992; Franklin et al., 1994; Tesfaye et al., 1996; Adler et al., 1997).”
BackgroundMethodInfluentialRapid Automated Diagnosis of Diabetic Peripheral Neuropathy With In Vivo Corneal Confocal Microscopy
Petropoulos, I. N., Alam, U., Fadavi, H., Marshall, A., Asghar, O., Dabbah, M. A., Chen, X., Graham, J., Ponirakis, G., Boulton, A. J. M., et al. (2014) · Investigative Opthalmology & Visual Science · doi:10.1167/iovs.13-13787 · Cited by 231
Peripheral Neuropathy in Diabetes Mellitus: Pathogenetic Mechanisms and Diagnostic Options
Galiero, R., Caturano, A., Vetrano, E., Beccia, D., Brin, C., Alfano, M., Di Salvo, J., Epifani, R., Piacevole, A., Tagliaferri, G., et al. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24043554 · Cited by 225
“As demonstrated by some trials, diabetic peripheral neuropathy (DPN) often is not present at the moment of diagnosis, while it could appear after at least 10 years of disease duration, and could affect up to 34% of subjects after ~25 years [5,6].”
BackgroundRisk Factors and Comorbidities in Diabetic Neuropathy: An Update 2015
Papanas, N., & Ziegler, D. (2015) · The Review of Diabetic Studies · doi:10.1900/rds.2015.12.48 · Cited by 207
Price, R., Smith, D., Franklin, G., Gronseth, G., Pignone, M., David, W. S., Armon, C., Perkins, B. A., Bril, V., Rae-Grant, A., et al. (2022) · Neurology · doi:10.1212/wnl.0000000000013038 · Cited by 193
Kempler, P., Tesfaye, S., Chaturvedi, N., Stevens, L. K., Webb, D. J., Eaton, S., Kerényi, Z., Tamás, G., Ward, J. D., Fuller, J. H., et al. (2002) · Diabetic Medicine · doi:10.1046/j.1464-5491.2002.00821.x · Cited by 203
Self-citationBastyr, E. J., Price, K. L., & Bril, V. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.002 · Cited by 202
Sadosky, A., McDermott, A. M., Brandenburg, N. A., & Strauss, M. (2008) · Pain Practice · doi:10.1111/j.1533-2500.2007.00164.x · Cited by 197
Genetic predictors of human chronic pain conditions
Zorina-Lichtenwalter, K., Meloto, C. B., Khoury, S., & Diatchenko, L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.04.041 · Cited by 194
“Exacerbated by pro - longed diabetic condition , glycemic mismanagement ( Tesfaye et al .”
Foot complications in Type 2 diabetes: an Australian population‐based study
Tapp, R. J., Shaw, J. E., De Courten, M. P., Dunstan, D. W., Welborn, T. A., & Zimmet, P. Z. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00881.x · Cited by 193
Stracke, H., Gaus, W., Achenbach, U., Federlin, K., & Bretzel, R. G. (2008) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/s-2008-1065351 · Cited by 192
“Even with optimal blood glucose control (HbA 1c 6.7 ± 1.9 % ) 28 % of insulin-dependent patients showed diabetic neuropathy in a large Europe-wide study ( Tesfaye et al., 1996 ).”
BackgroundInfluentialCabezas-Cerrato, J. (1998) · Diabetologia · doi:10.1007/s001250051063 · Cited by 192
A new look at painful diabetic neuropathy
Sloan, G., Shillo, P., Selvarajah, D., Wu, J., Wilkinson, I. D., Tracey, I., Anand, P., & Tesfaye, S. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.08.020 · Cited by 189
Self-citationLocal regulation of fat metabolism in peripheral nerves
Verheijen, M. H. G., Chrast, R., Burrola, P., & Lemke, G. (2003) · Genes & Development · doi:10.1101/gad.1116203 · Cited by 165
“Furthermore, ongoing storage lipid metabolism in both the adipose epineurium and in Schwann cells may be related to the high prevalence (∼30%) of peripheral neuropathies in both insulin-dependent (type I) and independent (type II) diabetes mellitus (Tesfaye et al. 1996).”
BackgroundPotential risk factors for diabetic neuropathy: a case control study
Booya, F., Bandarian, F., Larijani, B., Pajouhi, M., Nooraei, M., & Lotfi, J. (2005) · BMC Neurology · doi:10.1186/1471-2377-5-24 · Cited by 185
Cardiovascular autonomic neuropathies as complications of diabetes mellitus
Kuehl, M., & Stevens, M. J. (2012) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2012.21 · Cited by 181
Andreassen, C. S., Jakobsen, J., & Andersen, H. (2006) · Diabetes · doi:10.2337/diabetes.55.03.06.db05-1237 · Cited by 178
“Several studies have documented a high prevalence of neuropathy in diabetic patients ranging from 28 to 66%, depending on the definition of the neuropathy applied (1,9,17,18).”
BackgroundAdvances in Screening, Early Diagnosis and Accurate Staging of Diabetic Neuropathy
Carmichael, J., Fadavi, H., Ishibashi, F., Shore, A. C., & Tavakoli, M. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.671257 · Cited by 176
“In a cohort of patients with T1DM, the EURODIAB prospective complications (25) study reported similar modi fi able risk factors to those identi fi ed in T2DM, explicitly having an association with raised triglyceride level, obesity, smoking and hypertension.”
BackgroundBuyken, A. E., Toeller, M., Heitkamp, G., Karamanos, B., Rottiers, R., Muggeo, M., & Fuller, J. H. (2001) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/73.3.574 · Cited by 179
Self-citationDiabetic microvascular complications: can patients at risk be identified? A review
GIRACH, A., MANNER, D., & PORTA, M. (2006) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2006.01175.x · Cited by 177
Asadi, S., Gholami, M. S., Siassi, F., Qorbani, M., Khamoshian, K., & Sotoudeh, G. (2019) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2019.02.014 · Cited by 176
Alcohol consumption is inversely associated with adherence to diabetes self‐care behaviours
Ahmed, A. T., Karter, A. J., & Liu, J. (2006) · Diabetic Medicine · doi:10.1111/j.1464-5491.2006.01878.x · Cited by 174
Early Involvement of the Spinal Cord in Diabetic Peripheral Neuropathy
Selvarajah, D., Wilkinson, I. D., Emery, C. J., Harris, N. D., Shaw, P. J., Witte, D. R., Griffiths, P. D., & Tesfaye, S. (2006) · Diabetes Care · doi:10.2337/dc06-0650 · Cited by 170
Self-citationPrevalence of peripheral neuropathy in patients with diabetes: A systematic review and meta-analysis
Sun, J., Wang, Y., Zhang, X., Zhu, S., & He, H. (2020) · Primary Care Diabetes · doi:10.1016/j.pcd.2019.12.005 · Cited by 166
Vinik, A. I., Bril, V., Kempler, P., Litchy, W. J., Tesfaye, S., Price, K. L., & Bastyr, E. J. (2005) · Clinical Therapeutics · doi:10.1016/j.clinthera.2005.08.001 · Cited by 171
Self-citationVeglio, M., Borra, M., Stevens, L. K., Fuller, J. H., & Perin, P. C. (1999) · Diabetologia · doi:10.1007/s001250051115 · Cited by 167
Self-citationAdvanced Glycation End Products (AGEs) and Diabetic Vascular Complications
Yamagishi, S.-I., Nakamura, K., & Imaizumi, T. (2005) · Current Diabetes Reviews · doi:10.2174/1573399052952631 · Cited by 165
“Diabetic neuropathy is associated with risk factors for other vascular complications such as poor metabolic control, dyslipidemia, hypertension, body mass index, smoking, microalbuminuria and retinopathy [135-137].”
BackgroundClair, C., Cohen, M. J., Eichler, F., Selby, K. J., & Rigotti, N. A. (2015) · Journal of General Internal Medicine · doi:10.1007/s11606-015-3354-y · Cited by 163
Drug Treatment Effects on Disease Progression
Chan, P., & Holford, N. (2001) · Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev.pharmtox.41.1.625 · Cited by 160
Bjornstad, P., Dart, A. B., Donaghue, K. C., Dost, A., Feldman, E. L., Tan, G. S. W., Wadwa, R. P., Zabeen, B., & Marcovecchio, M. L. (2022) · Pediatric Diabetes · doi:10.1111/pedi.13444 · Cited by 195
Continued Reduction in the Prevalence of Retinopathy in Adolescents With Type 1 Diabetes
Downie, E., Craig, M. E., Hing, S., Cusumano, J., Chan, A. K. F., & Donaghue, K. C. (2011) · Diabetes Care · doi:10.2337/dc11-0102 · Cited by 153
“fewer injections actually reduced the risk of peripheral nerve abnormalities without the more usual variables increasing the risk (7,25).”
Kamei, N., Yamane, K., Nakanishi, S., Yamashita, Y., Tamura, T., Ohshita, K., Watanabe, H., Fujikawa, R., Okubo, M., & Kohno, N. (2004) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2003.12.006 · Cited by 162
Treatment of Chronic Painful Diabetic Neuropathy With Isosorbide Dinitrate Spray
Yuen, K. C. J., Baker, N. R., & Rayman, G. (2002) · Diabetes Care · doi:10.2337/diacare.25.10.1699 · Cited by 150
“CONCLUSIONS — Good glycemic control delays or prevents the onset of diabetic neuropathy (11,12) and ameliorates symptoms in those with acute painful neuropathy (13).”
BackgroundThe prevalence, patterns and predictors of diabetic peripheral neuropathy in a developing country
Katulanda, P., Ranasinghe, P. D., Jayawardena, R., Constantine, G. R., Sheriff, M. H. R., & Matthews, D. R. (2012) · Diabetology & Metabolic Syndrome · doi:10.1186/1758-5996-4-21 · Cited by 169
Al-Mahroos, F., & Al‐Roomi, K. (2007) · Annals of Saudi Medicine · doi:10.5144/0256-4947.2007.25 · Cited by 146
“Age (years and range) 52 (18-75) 54 (18-77) 56 (18-77) 58 (18-77) <0.”
Giorgino, F., Laviola, L., Perin, P. C., Solnica, B., Fuller, J., & Chaturvedi, N. (2004) · Diabetologia · doi:10.1007/s00125-004-1413-8 · Cited by 148
“Diabetic peripheral neuropathy was diagnosed as reported previously [2, 5], on the basis of: (i) presence of one or more neuropathic symptoms; (ii) absence of two or more ankle or knee reflexes; and (iii) abnormal vibration perception threshold, measured by centrally calibrated biothesiometers (Biomedical, Newbury, Oh…”
BackgroundSelf-citationCharcot Arthropathy of the Diabetic Foot. Current Concepts and Review of 36 Cases
Pakarinen, T.-K., Laine, H. ‐., Honkonen, S. E., Peltonen, J., Oksala, H., & Lahtela, J. T. (2002) · Scandinavian Journal of Surgery · doi:10.1177/145749690209100212 · Cited by 140
Assessment and treatment of diabetic foot ulcer
Fard, A. S., Esmaelzadeh, M., & Larijani, B. (2007) · International Journal of Clinical Practice · doi:10.1111/j.1742-1241.2007.01534.x · Cited by 140
Diabetic Painful Neuropathy: Current and Future Treatment Options
Chong, M. S., & Hester, J. (2007) · Drugs · doi:10.2165/00003495-200767040-00006 · Cited by 141
Impact of Overweight on Chronic Microvascular Complications in Type 1 Diabetic Patients
De Block, C. E. M., De Leeuw, I. H., & Van Gaal, L. F. (2005) · Diabetes Care · doi:10.2337/diacare.28.7.1649 · Cited by 138
Hydrogel dressings for healing diabetic foot ulcers
Dumville, J. C., O'Meara, S., Deshpande, S., & Speak, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009101.pub3 · Cited by 128
Understanding the impact of painful diabetic neuropathy
Quattrini, C., & Tesfaye, S. (2003) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.360 · Cited by 137
Self-citationRole of advanced glycation endproducts and glyoxalase I in diabetic peripheral sensory neuropathy
Jack, M. M., & Wright, D. E. (2012) · Translational research · doi:10.1016/j.trsl.2011.12.004 · Cited by 155
“A number of large studies have clearly identified hyperglycemia as a key feature involved in the pathogenesis of diabetic neuropathy [9, 28-30].”
Recent advances in the management of diabetic distal symmetrical polyneuropathy
Tesfaye, S. H. (2011) · Journal of Diabetes Investigation · doi:10.1111/j.2040-1124.2010.00083.x · Cited by 137
Self-citationAltered Age-Related Blood Pressure Pattern in Type 1 Diabetes
Rönnback, M., Fagerudd, J., Forsblom, C., Pettersson-Fernholm, K., Reunanen, A., & Groop, P.-H. (2004) · Circulation · doi:10.1161/01.cir.0000139903.29522.8d · Cited by 132
Prevalence of risk factors for diabetic foot complications
Al‐Maskari, F., & Sadig, M. E. (2007) · BMC Family Practice · doi:10.1186/1471-2296-8-59 · Cited by 150
“The results are consistent with findings elsewhere [18,25-29].”
ResultPeripheral neuropathy and the risk of cardiovascular events in type 2 diabetes mellitus
Brownrigg, J. R. W., de Lusignan, S., McGovern, A., Hughes, C., Thompson, M. M., Ray, K. K., & Hinchliffe, R. J. (2014) · Heart · doi:10.1136/heartjnl-2014-305657 · Cited by 130
Mohsin, F., Craig, M. E., Cusumano, J., Chan, A. K. F., Hing, S., Lee, J. W., Silink, M., Howard, N. J., & Donaghue, K. C. (2005) · Diabetes Care · doi:10.2337/diacare.28.8.1974 · Cited by 129
“Increasing height was associated with peripheral neuropathy in the EURODIAB IDDM Complications Study (34) and clinical neuropathy in the DCCT baseline study (35).”
BackgroundSadosky, A., Mardekian, J., Parsons, B., Hopps, M., Bienen, E. J., & Markman, J. D. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.10.013 · Cited by 129
Chattopadhyay, M., Mata, M. M., & Fink, D. J. (2008) · Journal of Neuroscience · doi:10.1523/jneurosci.5530-07.2008 · Cited by 126
“Distal symmetric sensorimotor polyneuropathy is a common complication of diabetes mellitus, affecting up to 50% of patients with diabetes (Tesfaye et al., 1996).”
BackgroundHydrocolloid dressings for healing diabetic foot ulcers
Dumville, J. C., Deshpande, S., O'Meara, S., & Speak, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009099.pub3 · Cited by 121
Verier‐Mine, O., Chaturvedi, N., Webb, D., Fuller, J., & The EURODIAB Prospective Complications Study Group (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01682.x · Cited by 129
Self-citationThe pathogenesis and management of painful diabetic neuropathy: a review
Spruce, M. C., Potter, J., & Coppini, D. V. (2003) · Diabetic Medicine · doi:10.1046/j.1464-5491.2003.00852.x · Cited by 122
Diabetic microvascular complications—can the presence of one predict the development of another?
Girach, A., & Vignati, L. (2006) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2006.03.001 · Cited by 128
Thermal Thresholds Predict Painfulness of Diabetic Neuropathies
Krämer, H. H., Rolke, R., Bickel, A., & Birklein, F. (2004) · Diabetes Care · doi:10.2337/diacare.27.10.2386 · Cited by 130
“D iabetic neuropathy (DN) is the most frequent neuropathy in western countries and affects 60% of all diabetic patients (1).”
BackgroundAlginate dressings for healing diabetic foot ulcers
Dumville, J. C., O'Meara, S., Deshpande, S., & Speak, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009110.pub3 · Cited by 117
Tesfaye, S. H., Selvarajah, D., Gandhi, R. A., Greig, M., SHILLO, P. R., Fang, F., & Wilkinson, I. D. (2015) · Pain · doi:10.1097/j.pain.0000000000000465 · Cited by 135
Self-citationKrishnan, S. T. M., & Rayman, G. (2004) · Diabetes Care · doi:10.2337/diacare.27.12.2930 · Cited by 117
Corneal confocal microscopy: ready for prime time
Petropoulos, I. N., Ponirakis, G., Khan, A., Gad, H., Almuhannadi, H., Brines, M. L., Cerami, A., & Malik, R. A. (2019) · Clinical and Experimental Optometry · doi:10.1111/cxo.12887 · Cited by 122
An overview of the Charcot foot pathophysiology
Kaynak, G., Birsel, O., Güven, M. F., & Öğüt, T. (2013) · Diabetic Foot & Ankle · doi:10.3402/dfa.v4i0.21117 · Cited by 119
“In the European Diabetes Centers study of complications in patients with insulin-dependent diabetes mellitus (EURODIAB IDDM), in which a considerable number of diabetic patients were included, the overall prevalence of neuropathy was 28% (25).”
BackgroundLu, Y., Xing, P., Cai, X., Luo, D., Li, R., Lloyd, C. E., Sartorius, N., & Li, M. (2020) · Frontiers in Public Health · doi:10.3389/fpubh.2020.534372 · Cited by 148
Boulton, A. J. M., & Malik, R. A. (1998) · Medical Clinics of North America · doi:10.1016/s0025-7125(05)70029-8 · Cited by 112
Jaiswal, M., Lauer, A., Martin, C. L., Bell, R. A., Divers, J., Dabelea, D., Pettitt, D. J., Saydah, S., Pihoker, C., Standiford, D. A., et al. (2013) · Diabetes Care · doi:10.2337/dc13-1213 · Cited by 108
“Furthermore, early detection and good glycemic control have been proven to prevent or delay adverse outcomes associated with DPN (5,8,9).”
BackgroundFoam dressings for healing diabetic foot ulcers
Dumville, J. C., Deshpande, S., O'Meara, S., & Speak, K. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd009111.pub3 · Cited by 92
Hicks, C. W., Canner, J. K., Mathioudakis, N. N., Lippincott, C. K., Sherman, R. L., & Abularrage, C. J. (2019) · Journal of Surgical Research · doi:10.1016/j.jss.2019.09.025 · Cited by 129
Advances in the management of diabetic peripheral neuropathy
Tesfaye, S. (2009) · Current Opinion in Supportive & Palliative Care · doi:10.1097/spc.0b013e32832b7df5 · Cited by 105
Self-citationCurrie, C. J., Poole, C., Woehl, A., Morgan, C. L., Cawley, S., Rousculp, M. D., Covington, M., & Peters, J. R. (2006) · Diabetologia · doi:10.1007/s00125-006-0380-7 · Cited by 105
“The most common form of DPN is detected in about 30% of type 1 and type 2 patients [2, 3].”
Background
Metadata
- Authors
- Tesfaye, S., Stevens, L. K., Stephenson, J. M., Fuller, J. H., Plater, M., Ionescu-Tirgoviste, C., Nuber, A., Pozza, G., & Ward, J. D.
- Affiliations
- Royal Liverpool University Hospital (GB)
- University College London (GB)
- Royal Hallamshire Hospital (GB)
- München Klinik Schwabing (DE)
- IRCCS Ospedale San Raffaele (IT)
- Venue
- Diabetologia
- Published
- 1996-10-23
- Volume
- 39
- Issue
- 11
- Pages
- 1377-1384
- ISSN
- 0012-186X (ISSN-L)
- 1432-0428
- OpenAlex
- W2049568996
- Cited by
- 695
- References
- 30
- Citations by year
- 2026: 7 · 2025: 20 · 2024: 17 · 2023: 30 · 2022: 27 · 2021: 34 · 2020: 32 · 2019: 30 · 2018: 35 · 2017: 23 · 2016: 27 · 2015: 36 · 2014: 41 · 2013: 36 · 2012: 27
- FWCI
- 7.52
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Diabetologia (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Funders
- Pfizer
- Novo Nordisk
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetic Foot Ulcer Assessment and Management
- Health Sciences › Medicine › Clinical Neurology › Peripheral Neuropathies and Disorders
- Health Sciences › Medicine › Physiology (medical) › Pain Mechanisms and Treatments
- Keywords
- diabetic peripheral neuropathy, prevalence, type 1 diabetes, glycemic control, risk factors, diabetes duration, diabetic retinopathy, smoking, HDL cholesterol, cardiovascular disease, diastolic blood pressure, ketoacidosis, fasting triglycerides, microalbuminuria, autonomic dysfunction, erectile dysfunction, alcohol consumption
- MeSH terms
- Adolescent, Adult, Blood Pressure, Body Constitution, Cardiovascular Diseases, Diabetes Mellitus, Type 1, Diabetic Neuropathies, Diabetic Retinopathy, Europe, Female, Humans, Hypoglycemia, Lipids, Male, Middle Aged, Peripheral Nervous System Diseases, Regression Analysis, Risk Factors, Smoking, Body Mass Index, Prevalence, Diabetic Ketoacidosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.